Table 2.
Hemoglobin A1c concentrations by hormonal quartile among 200 non HT users postmenopausal women in the Women's Health Study.
| Serum Markers | Model 1* | Model 2** |
|---|---|---|
| SHBG, nmol/L† | ||
| Quartile 1 | 5.34 | 5.31 |
| Quartile 2 | 5.14 | 5.11 |
| Quartile 3 | 5.08 | 5.111 |
| Quartile 4 | 5.09 | 5.14 |
| p for trend | 0.003 | 0.09 |
| Testosterone, ng/dL† | ||
| Quartile 1 | 5.10 | 5.11 |
| Quartile 2 | 5.19 | 5.21 |
| Quartile 3 | 5.13 | 5.12 |
| Quartile 4 | 5.24 | 5.22 |
| p for trend | 0.12 | 0.37 |
| Estradiol, pg/mL† | ||
| Quartile 1 | 5.07 | 5.12 |
| Quartile 2 | 5.17 | 5.19 |
| Quartile 3 | 5.23 | 5.22 |
| Quartile 4 | 5.15 | 5.08 |
| p for trend | 0.25 | 0.25 |
| FAI, nmol/L† | ||
| Quartile 1 | 5.04 | 5.09 |
| Quartile 2 | 5.12 | 5.13 |
| Quartile 3 | 5.22 | 5.20 |
| Quartile 4 | 5.28 | 5.24 |
| p for trend | 0.003 | 0.04 |
| FEI, nmol/L† | ||
| Quartile 1 | 5.07 | 5.12 |
| Quartile 2 | 5.07 | 5.09 |
| Quartile 3 | 5.21 | 5.20 |
| Quartile 4 | 5.29 | 5.22 |
| p for trend | 0.22 | 0.64 |
HT= hormone therapy
†
Geometric means.
*
Model 1: Adjusted for development of CVD and age
**
Model 2: Adjusted for development of CVD, age and BMI